Expert Opinion on Pharmacotherapy

Synthetic dopamine agonists
pp. 363-364(2)
Author: Calne D.B.

Is pharmacological prevention of Alzheimer's a realistic goal?
pp. 365-380(16)
Authors: Anthony J.C.; Breitner J.C.; Zandi P.P.

Drug treatment of non-motor symptoms in Parkinson’s disease
pp. 381-388(8)
Authors: Müller T.

Pregnancy and chronic headache
pp. 389-393(5)
Author: Marcus D.A.

Nitric oxide synthase inhibitors for the treatment of chronic tension-type headache
pp. 395-399(5)
Author: Ashina M.

Combining antiplatelet and thrombolytic therapies for stroke
pp. 401-410(10)
Author: Bednar M.M.

Treatment options for renovascular hypertension
pp. 411-416(6)
Author: Spence J.D.

Pharmacoeconomics of long-term treatment of rheumatoid arthritis
pp. 417-422(6)
Authors: Tugwell P.; Blumenauer B.; Coyle D.

Treatment of breast cancer during pregnancy
pp. 423-428(6)
Authors: Partridge A.H.; Lesnikoski B-A.; Burstein H.J.

The complex relationship between pregnancy andbreast cancer
pp. 429-431(3)
Author: Surbone A.

Rasburicase: a potent uricolytic agent
pp. 433-442(10)
Author: Pui C-H.

Oxybutynin chloride: alterations in drug delivery and improved therapeutic index
pp. 443-454(12)
Authors: Dmochowski R.; Staskin D.; Kell S.

Fondaparinux versus enoxaparin for the prevention of venous thromboembolism
pp. 455-457(3)
Author: Doggrell S.A.